HPB
CME
Julie Hallet, MD MSc FRCSC FSSO (she/her/hers)
Associate Professor
Department of Surgery, Division of General Surgery, University of Toronto
Toronto, Canada
Disclosure(s): Asana BioSciences, LLC; Bristol-Myers Squibb; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Replimune Group Inc: Speaker (Ongoing); Ipsen: Speaker (Ongoing)
In this exciting debate, we pit two highly experienced HPB surgeons against each other in the age-old question of whether to chase intraoperative margins during a pancreatoduodenectomy. They will review the available data and seek to convince you of their viewpoint on this hot topic.
Debater: David A. Kooby, MD, FACS (he/him/his) – Winship Cancer Institute, Division of Surgical Oncology, Emory University
Debater: Alice C. Wei, MD, MS, FRCSC (she/her/hers) – Memorial Sloan Kettering Cancer Center
Debater: David A. Kooby, MD, FACS (he/him/his) – Winship Cancer Institute, Division of Surgical Oncology, Emory University
Debater: Alice C. Wei, MD, MS, FRCSC (she/her/hers) – Memorial Sloan Kettering Cancer Center